找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Coronary Microvascular Dysfunction; Filippo Crea,Gaetano A. Lanza,Paolo G. Camici Book 2014 The Editor(s) (if applicable) and The Author(s

[復(fù)制鏈接]
樓主: Enkephalin
11#
發(fā)表于 2025-3-23 09:43:17 | 只看該作者
Health promotion in the workplace,d myocardial damage in patients undergoing CABG surgery have included ischemic conditioning and drugs, as adenosine and acadesine, diazoxide, volatile anesthetic agents, anti-inflammatory agents, statins and sodium–hydrogen exchange inhibitors. The results achieved with these forms of treatment are discussed in this chapter.
12#
發(fā)表于 2025-3-23 14:58:45 | 只看該作者
ormation on the prevention and treatment of coronary microva.In the past two decades a number of studies have shown that abnormalities in the function and structure of coronary microcirculation can be detected in several cardiovascular diseases.?On the basis of the clinical setting in which it occur
13#
發(fā)表于 2025-3-23 19:35:06 | 只看該作者
14#
發(fā)表于 2025-3-23 23:14:54 | 只看該作者
15#
發(fā)表于 2025-3-24 05:31:48 | 只看該作者
16#
發(fā)表于 2025-3-24 08:06:23 | 只看該作者
17#
發(fā)表于 2025-3-24 14:15:03 | 只看該作者
Treatment of Primary CMDthis chapter. While the pharmacological approach to acute MVA still waits to be defined, treatment of takotsubo disease is mainly based on the control of hemodynamic state, due to the usual spontaneous improvement of the disease.
18#
發(fā)表于 2025-3-24 16:30:22 | 只看該作者
Treatment of CMD in Obstructive CADcluding pharmacological (e.g., adenosine, nitroprusside) and nonpharmacological (e.g., antiembolic devices, ischemic conditioning) tools. This chapter discusses the main results observed with these interventions in these clinical settings.
19#
發(fā)表于 2025-3-24 19:56:12 | 只看該作者
20#
發(fā)表于 2025-3-25 00:34:01 | 只看該作者
Book 2014to the pathogenesis of myocardial ischemia,?thus becoming a possible therapeutic target.?This book provides an update on coronary?physiology?and a systematic assessment of microvascular abnormalities in cardiovascular diseases,?in the hope that it will assist clinicians in prevention, detection?and management of CMD in their everyday activity..
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-24 19:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
东乡县| 兴山县| 新竹市| 舞钢市| 通河县| 都安| 乌鲁木齐市| 凌云县| 静海县| 历史| 岢岚县| 宁远县| 区。| 南城县| 蒲城县| 宜丰县| 贡觉县| 隆尧县| 商都县| 旌德县| 合山市| 陆川县| 晋宁县| 乐东| 曲水县| 云梦县| 梅州市| 合作市| 彩票| 平乡县| 新竹市| 马尔康县| 岳普湖县| 宁陕县| 千阳县| 泽普县| 贡山| 阿拉尔市| 罗源县| 明水县| 江安县|